Crexendo, Inc. (CXDO) CFO trades options and stock, holding 183,345 shares
Rhea-AI Filing Summary
Crexendo, Inc. Chief Financial Officer Vincent Ron reported option-related trades in Common Stock on August 7, 2025. He exercised options on 18,050 and 4,860 shares at $2.72 per share, with the company withholding shares to cover the exercise price and payroll taxes, and sold 8,200 shares at $6.518 per share under a Rule 10b5-1(c) plan adopted on December 9, 2024. After these transactions he directly held 183,345 shares of common stock.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine pre‑planned sale plus in‑the‑money option exercises; results are largely mechanical, not a firm valuation signal.
The Form 4 documents a 10b5-1 sale of 8,200 shares and contemporaneous net exercises of options that generated 7,732 and 2,866 shares to the reporting person, with 10,318 and 1,994 shares withheld for exercise costs and taxes using a closing price of $6.63. The option exercise price is $2.72, so the exercises were materially in the money on the settlement date, creating realized economic value for the executive. Overall, these are common executive liquidity and compensation events documented as required; they do not by themselves change the company’s operating fundamentals.
TL;DR: Use of a documented 10b5-1 plan and disclosure of net exercises reflects compliance with insider trading rules.
The report explicitly states the sale was executed under a Rule 10b5-1(c) plan adopted on 12/09/2024 and confirms the filer attested to lack of material nonpublic information at plan adoption. Net exercises are disclosed with the number of shares withheld to satisfy exercise/payment obligations, and vesting schedules are specified (36 monthly installments beginning 11/24/2022). From a governance perspective, the filing shows adherence to standard disclosure and compensation mechanics; it documents liquidity and option exercise activity without indicating deviations from policy.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Options | 18,050 | $2.72 | $49K |
| Exercise | ISO Stock Options | 4,860 | $2.72 | $13K |
| Sale | Common Stock | 8,200 | $6.518 | $53K |
| Exercise | Common Stock | 18,050 | $2.72 | $49K |
| Exercise Price or Tax Liability | Common Stock | 10,318 | $6.63 | $68K |
| Exercise | Common Stock | 4,860 | $2.72 | $13K |
| Exercise Price or Tax Liability | Common Stock | 1,994 | $6.63 | $13K |
Footnotes (4)
- F1. This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 9, 2024, at which time Mr. Vincent was not aware of material nonpublic information.
- F2. Represents a "net exercise" of outstanding stock options. The reporting person received 7,732 shares of common stock on net exercise of option to purchase 18,050 shares of common stock. The Company withheld 10,318 shares of common stock underlying the option for payment of the exercise price and associated payroll taxes, using the closing stock price on August 7, 2025 of $6.63, This transaction does not represent a sale by the reporting person.
- F3. The stock options are vesting over 36 equal monthly installments beginning on 11/24/2022.
- F4. Represents a "net exercise" of outstanding stock options. The reporting person received 2,866 shares of common stock on net exercise of option to purchase 4,860 shares of common stock. The Company withheld 1,994 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on August 7, 2025 of $6.63, This transaction does not represent a sale by the reporting person.
Key Figures
Key Terms
Rule 10b5-1(c) regulatory
net exercise financial
ISO Stock Options financial
Non-Qualified Stock Options financial
AI-generated analysis. How Rhea-AI works. Not financial advice.